Prof Andriana Margariti

Professor Andriana Margariti holds a BSc in Biochemistry from the University of East London (2003), an MSc in Biomedical Sciences (Haematology) from Kingston University, London (2004), and a PhD in Cardiovascular Medicine and Stem Cells from King’s College London (2008). She is also an Associate Fellow of the Higher Education Academy (2013). Over the course of her career, Professor Margariti has established herself as a leading authority in vascular biology, regenerative medicine, and stem cell research, with a strong focus on translational science that bridges fundamental discovery with clinical application. Her academic training and international research fellowships at world-renowned institutions, including Harvard University, UCSF, and King’s College London, have positioned her at the forefront of innovation in cardiovascular and regenerative medicine.

Her research is internationally recognised for advancing the fields of cellular engineering, personalised medicine, and organoid technologies. With particular expertise in induced pluripotent stem cell (iPSC) technologies, Professor Margariti has developed and optimised state-of-the-art platforms for disease modelling, enabling the recreation of complex patient-specific conditions in vitro. She has pioneered protocols for endothelial cell differentiation and the generation of next-generation vascularised cardiac organoids, offering unique opportunities to investigate the mechanisms of cardiovascular disease, diabetes, autoimmune disorders, genetic conditions, and cancer. These models provide not only an unparalleled window into the cellular and molecular basis of human disease but also a robust platform for drug discovery, regenerative therapies, and precision medicine. By integrating stem cell biology with bioengineering approaches and vascular modelling, her work exemplifies the future of translational regenerative medicine, accelerating the pathway from bench to bedside and creating innovative solutions to some of the most pressing global health challenges.